Do you really? Except for certain pharmaceuticals, it seems like there are alternate suppliers for most European exports. Right now 15% is the rate for most of your competitors, as well. Doing anything other than rolling over would mean higher tariffs and losing out to China/APEC/MERCOSUR in the American market. To me it seems like the best course of action is to agree with this in the short term, and try to gradually decrease your reliance on the American consumer. Right now the US is by far your biggest export market, and losing access would be unfortunate.
Do you really? Except for certain pharmaceuticals, it seems like there are alternate suppliers for most European exports. Right now 15% is the rate for most of your competitors, as well. Doing anything other than rolling over would mean higher tariffs and losing out to China/APEC/MERCOSUR in the American market. To me it seems like the best course of action is to agree with this in the short term, and try to gradually decrease your reliance on the American consumer. Right now the US is by far your biggest export market, and losing access would be unfortunate.